BioIndustry Ethics
Latest Publications

TOTAL DOCUMENTS

19

(FIVE YEARS 0)

H-INDEX

0

(FIVE YEARS 0)

Published By Elsevier

9780123693709

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

AFFYMETRIX, INC.: USING CORPORATE ETHICS ADVICE11This case study was written by Margaret L. Eaton based on interviews with three Affymetrix employees and five ethics advisors in July and August 2003. Two of the interviews were conducted with David Finegold, who also gave valuable assistance in editing this case study, as did Abdallah Daar. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring informed ethical decision making in bioscience firms. Grateful appreciation is extended to all those who participated and assisted, especially to Affymetrix's Katie Tillman Buck, without whose efforts this case study could not have been written.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50032-x ◽

2005 ◽

pp. 219-249

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Ethical Decision ◽

Ethical Decision Making ◽

Corporate Ethics

Download Full-text

SCIONA LTD.: A PIONEER IN NUTRIGENOMICS: THE PATH TO CONSUMER ACCEPTANCE11This case study was written by Cécile M. Bensimon under the supervision of Peter Singer, following interviews they conducted with Sciona executives and ethics consultants in November 2002. We would like to acknowledge Martin Tierney's work on the study, and Abdallah Daar, Margaret Eaton and David Finegold provided constructive comments and edits on earlier drafts. This case study is one in a series produced under a grant by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. Unless otherwise specified, all attributed quotes were obtained during the case study interviews. We would like to thank all who participated in the case study, especially Rosalynn Gill-Garrison, whose invaluable assistance enabled us to complete this study.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50031-8 ◽

2005 ◽

pp. 201-218

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Ethical Decision ◽

Ethical Decision Making ◽

Download Full-text

PREFACE

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50020-3 ◽

2005 ◽

pp. IX-X

Author(s):

David L. Finegold

Download Full-text

NOVO NORDISK: THE TRIPLE BOTTOM LINE11This case study was written by Jocelyn E. Mackie under the supervision of Abdallah S. Daar. All data for this case come from interviews performed by Daar and Mackie on March 15–17, 2004, at Novo Nordisk, unless otherwise noted. This case is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. We would like to thank all the employees of Novo Nordisk who took part in this study.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50035-5 ◽

2005 ◽

pp. 301-329

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Ethical Decision ◽

Ethical Decision Making

Download Full-text

INDEX

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50037-9 ◽

2005 ◽

pp. 355-368

Download Full-text

INTERLEUKIN GENETICS AND ALTICOR: AN UNLIKELY PARTNERSHIP11This case study was written by David Finegold based on interviews conducted on October 1, 2003 at Interleukin in Waltham, Massachusetts. Unless otherwise specified, all quotations that appear in the case were obtained during these interviews. Interviews were conducted by Finegold, Jocelyn Mackie, and Cécile M. Bensimon. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. We would especially like to thank Rahul Dhanda without whose help this case study would not have been possible.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50030-6 ◽

2005 ◽

pp. 183-200

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Ethical Decision ◽

Ethical Decision Making

Download Full-text

PIPELINE BIOTECH A/S: COMPETING REGULATORY REGIMES FOR LABORATORY ANIMAL EXPERIMENTS11This case study was written by David Finegold based on interviews he conducted with Pipeline employees and a company consultant. Interviews were conducted by phone or at the Keck Graduate Institute in Claremont, California in April to June 2004. Unless otherwise specified, all quotations were obtained during these interviews. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. Grateful appreciation is extended to all those who participated and assisted in this case study, especially to Rasmus Nelund, without whose efforts this case study could not have been written.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50028-8 ◽

2005 ◽

pp. 153-166

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Laboratory Animal ◽

Ethical Decision ◽

Ethical Decision Making ◽

Regulatory Regimes ◽

Download Full-text

MAXIM PHARMACEUTICALS (A): INTERNAL AND EXTERNAL DIALOGUES11This case study was written by David Finegold based on interviews he conducted with employees and a company consultant. Interviews were conducted with Beatrice Godard at Maxim and by phone in April 2003. Unless otherwise specified, all quotes were obtained during these interviews. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. Grateful appreciation is extended to all those who participated and assisted in this case study, especially to Larry Stambaugh, without whose efforts this case study could not have been written.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50026-4 ◽

2005 ◽

pp. 111-126

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Ethical Decision ◽

Ethical Decision Making ◽

Download Full-text

TGN BIOTECH: A START-UP WITH ETHICAL ROOTS11This case was written by Jocelyn E. Mackie under the supervision of Abdallah S. Daar and with the assistance of Cécile M. Bensimon. All information, unless otherwise stated, was gathered from personal interviews of employees at TGN Biotech in August 2003 conducted by Mackie, Daar, and Bensimon. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. Grateful appreciation is extended to all who participated and assisted in this case study, without whose efforts this case study could not have been written.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50029-x ◽

2005 ◽

pp. 167-182

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Ethical Decision ◽

Ethical Decision Making ◽

Download Full-text

PHARMASNPS INC.: CREATING AN ETHICS ADVISORY BOARD11This case study is of a real company that has been anonymized because the firm was acquired after the case was completed. The case study was written by Cécile M. Bensimon and David Finegold based on interviews they conducted on September 26, 2002 at Company headquarters. Four members of the company's EAB were also interviewed by phone. Unless otherwise specified, all quotes attributed to these people were obtained during interviews. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. The participation, suggestions, and assistance of all involved are greatly appreciated.

BioIndustry Ethics ◽

10.1016/b978-012369370-9/50033-1 ◽

2005 ◽

pp. 251-266

Author(s):

David L. Finegold ◽

Cécile M. Bensimon ◽

Abdallah S. Daar ◽

Margaret L. Eaton ◽

Béatrice Godard ◽

...

Keyword(s):

Decision Making ◽

Ethical Decision ◽

Ethical Decision Making

Download Full-text